Dr Shefali Khanna Sharma - Abstracts

  • Prasad CB, Dhir V, Naidu G, Sharma SK, Sharma A, Jain S. AB0209 Validation of revised 2022
    ACR/EULAR remission criteria for rheumatoid arthritis in Asian Indian rheumatoid arthritis patients. Ann
    Rheum Dis. 2023.
  • Machhua S, Minz R, Sharma SK, Kumar Y, Singh S, Anand S, Handa S. AB0843 The expression profiling
    of circulating miRNAs in systemic sclerosis. Ann Rheum Dis. 2023;82(Suppl 1):1634.2-5.
  • Kotwani S, Naidu G, Bhatia M, Sharda S, Dhir V, Sharma SK, Rathi M, Sharma A, Sharma N, Jain S.
    AB0613 Etiology, outcome and predictors of mortality among systemic lupus erythematosus patients
    presenting to emergency department: A single centre prospective study. Ann Rheum Dis. 2023;82(Suppl
    1):1507.3-8.
  • Dhir V, Shaji A, Prasad CB, Naidu G, Sharma A, Sharma SK, Jain S, Bhutungru S, Ghai B. AB0462
    Comparing injection of local anesthesia in overlying skin to not giving it prior to intraarticular injection of
    glucocorticoid: A randomized controlled trial. Ann Rheum Dis. 2023;1423.
  • Das D, Naidu G, Grover S, Dhir V, Sharma SK, Sharma A, Jain S, Deo P. AB0650 Prevalence of fatigue
    and its impact on quality of life in the patients with primary Sjogren’s syndrome. Ann Rheum Dis.
    2023;1527.
  • Mathew J, Kopp C, Sharma S, Dhir V, Dhooria S, Sinha A, Jain S. OP0240 A randomized controlled trial
    to compare the efficacy of tacrolimus with mycophenolate mofetil in patients with systemic sclerosis -
    interstitial lung disease (INSIST TRIAL). Ann Rheum Dis. 2023; 82:160.1-160.
  • Kotwani S, Naidu G, Bhatia M, Sharma SK, et al. AB0613 Etiology, outcome and predictors of mortality
    among systemic lupus erythematosus patients presenting to emergency department: A single centre
    prospective study. Ann Rheum Dis. 2023; 82:1507-8.
  • Das D, Naidu G, Grover S, Dhir V, Sharma S, Sharma A, Jain S, Deo P. AB0650 Prevalence of fatigue and
    its impact on quality of life in the patients with primary Sjogren’s syndrome. Ann Rheum Dis.
    2023;82(Suppl 1):1527.2-7.
  • Dhir V, Shaji A, Prasad CB, Naidu G, Sharma A, Sharma S, Jain S, Bhutungru S, Ghai B. AB0462
    Comparing injection of local anesthesia in overlying skin to not giving it prior to intraarticular injection of
    glucocorticoid: A randomized controlled trial. Ann Rheum Dis. 2023; 82:1423.1-3.
  • Jain S, Sharma SK, et al. Changes in serum levels of cytokines with methotrexate monotherapy in active
    rheumatoid arthritis: Results from a multicentre, randomized controlled trial on methotrexate escalation in
    rheumatoid arthritis. Rheumatology (Oxford). 2023;62(Suppl 2): P122.
  • Jain S, Dhir V, Aggarwal A, Sharma SK, et al. POS0566 Predictors of response to methotrexate
    monotherapy in active rheumatoid arthritis: Results from a multicentre, randomized controlled trial
    (MEIRA). Ann Rheum Dis. 2022; 81:548-9.
  • Jain S, Dhir V, Aggarwal A, et al. AB0276 How fast can methotrexate be escalated in rheumatoid arthritis?
    A multicentre, parallel group randomized controlled trial (MEIRA). Ann Rheum Dis. 2021; 80:1163-4.
  • Dhir V, V D, Jain S, Sharma SK, et al. POS0679 A new questionnaire and score (MISA) for assessing
    methotrexate intolerance in rheumatoid arthritis. Ann Rheum Dis. 2021; 80:584-5.
  • Mishra D, Naidu G, Kumar V, Sharma SK, et al. OP0108 Randomized controlled trial of oral corticosteroids
    in axial spondyloarthropathy: Modified COBRA regime. Ann Rheum Dis. 2020; 79:70-1.
  • Dhir V, Jha S, Sharma, Sharma SK, et al. AB0570 Mixed connective tissue disease: Not that uncommon, a
    single-center experience from India. Ann Rheum Dis. 2020; 79:1582.
  • Jha N, Misra S, Dhir DV, Chattopadhyay A, Jain S, Sharma S, et al. AB0395S systemic lupus associated
    macrophage activation syndrome – A single centre experience from India. Ann Rheum Dis. 2020;79(Suppl
    1):1497.2-7.
  • Acharya N, Sharma SK, et al. Efficacy of pirfenidone in systemic sclerosis related interstitial lung disease
    - A randomized controlled trial. Ann Rheum Dis. 2019;78(Suppl 2):200-1.
  • Sharma S, et al. SAT0468 Scleroderma-interstitial lung disease: Does maintenance therapy make a
    difference? Ann Rheum Dis. 2018.
  • Sharma S, Chinthala H, Jain S, Chattopadhyay A, Bahl P, Dhir V, Sachdeva N, Singh S. A comparison of
    risk of ovarian failure following intravenous cyclophosphamide therapy in juvenile versus adult systemic
    lupus erythematosus. Arthritis Rheumatol. 2019;71(Suppl 10).
  • Naidu GSR, Sharma SK, et al. Fri0445 A randomized controlled trial to compare the efficacy of oral
    mycophenolate mofetil with placebo in patients with systemic sclerosis related early interstitial lung
    disease. Ann Rheum Dis. 2018;77(Suppl 2):751.
  • Dwivedi P, Adarsh MB, Acharya N, Ramachandran R, Nada R, Sharma S, Dhir V, Jain S. Scleroderma
    renal crisis: High mortality despite angiotensin-converting enzyme inhibitors in India. Indian J Rheumatol.
    2018;13: S226.
  • Adarsh MB, Sharma SK, et al. Methotrexate in early Chikungunya arthritis: A 6-month randomized
    controlled open-label trial. Curr Rheumatol Rev. 2019; 15:1-1.
  • Sharma S, et al. SAT0468 Scleroderma-interstitial lung disease: Does maintenance therapy make a
    difference? Ann Rheum Dis. 2018 Jun;77(Suppl 2):1092.1-1092.
  • Naidu G, Sharma SK, et al. AB0633 Rituximab in scleroderma-related interstitial lung disease: A single-
    center experience from North India. Ann Rheum Dis. 2017;76(Suppl 2):1273-1274.
    Sharma S. To study the effect of methotrexate and prednisolone on tuberculin skin test in RA patients
    screened for latent TB, implications on anti TNF alpha therapy.
  • Sharma S, et al. A comparison of ovarian reserve in women with systemic lupus erythematosus following
    treatment with intravenous cyclophosphamide against those who received MMF. Lupus. 2017;26(4):491-
    491.
  • Sharma SK, Agarwal D, Dhir V, Singh S. CIMT is increased in patients of systemic sclerosis: Results from
    a tertiary center, cross-sectional, case-control study. APL16-0544.
  • Sharma S. Systemic sclerosis causes clinically apparent hand arthritis which is associated with radiographic
    changes on high-resolution US and MRI. APL16-0545.
  • Sinha A, Sharma S. Quantitative assessment of mean lung density with MDCT in scleroderma-associated
    interstitial lung disease: Correlation with pulmonary functional tests. In: 68th Proceedings of the Annual
    Conference of Indian Radiological & Imaging Association, Kochi, January 2015.
  • Kaur P, Sharma SK, et al. Effect of methotrexate on circulating T-helper subsets in rheumatoid arthritis.
    Indian J Rheumatol. 2014;9: S30.
  • Sharma A, Sharma SK, et al. Poncet’s disease: Retrospective case series from a high endemic country with
    a proposal of new diagnostic criteria. Indian J Rheumatol. 2014;9:S59.
  • Adarsh MB, Sharma SK, et al. Gastrointestinal manifestations of systemic sclerosis – Clinical and
    investigative study of 50 patients. Indian J Rheumatol. 2014;9:S29.
  • Sharma SK, Dhir V, et al. Does a higher dose of folic acid reduce adverse effects of methotrexate in
    rheumatoid arthritis? A randomized controlled trial. Indian J Rheumatol. 2014;9:S29.
  • Singh PK, Sharma SK, et al. Prevalence of thyroid dysfunction in patients with systemic sclerosis – A
    prospective cross-sectional study in a tertiary clinic in Northwest India. Indian J Rheumatol. 2014;9: S51.
  • Naidu GSR, Adarsh MB, Sharma SK, Dhir V. A randomized controlled trial to compare the efficacy of oral
    mycophenolate mofetil with placebo in patients with systemic sclerosis-related early interstitial lung
    disease. Indian J Rheumatol. 2018;13: S219.
  • Dhir V, Sharma SK, et al. Low serum levels of myeloid progenitor inhibitory factor-1 predict good response
    to methotrexate in rheumatoid arthritis. ISRN Inflamm. 2013; 2013:460469.
  • Dhir V, Sharma A, Khanna S. What is the right dose to start (7.5 or 15 mg) in rheumatoid arthritis? (A
    randomized controlled trial). Indian J Rheumatol. 2012;7: S34.
  • Sharma S, et al. O17 Signs of accelerated preclinical atherosclerosis in ankylosing spondylitis patients in
    India.
  • Sharma SK, et al. P37 Measuring disease activity in ankylosing spondylitis patient without peripheral
    arthritis with serum IL6.
  • Sharma SK, Bambery P. To develop and validate a health-related quality of life scale for rheumatoid
    arthritis patients in a North Indian setting. Intern Med J. 2007;37(2):S:A52.
  • Banga A, Khilnani GC, Sharma SK. Serum albumin as a prognostic marker in critically ill patients. J Assoc
    Physicians India. 2003;51:1223-1224.